FI951276A0 - Parannettuja ominaisuuksia omaavat vasta-ainekonjugaatit - Google Patents

Parannettuja ominaisuuksia omaavat vasta-ainekonjugaatit

Info

Publication number
FI951276A0
FI951276A0 FI951276A FI951276A FI951276A0 FI 951276 A0 FI951276 A0 FI 951276A0 FI 951276 A FI951276 A FI 951276A FI 951276 A FI951276 A FI 951276A FI 951276 A0 FI951276 A0 FI 951276A0
Authority
FI
Finland
Prior art keywords
antibody conjugates
enhanced properties
enhanced
properties
conjugates
Prior art date
Application number
FI951276A
Other languages
English (en)
Swedish (sv)
Other versions
FI951276A (fi
Inventor
Brendal Murray
Terence O'reilly
Gerd Pluschke
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of FI951276A0 publication Critical patent/FI951276A0/fi
Publication of FI951276A publication Critical patent/FI951276A/fi

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/6415Toxins or lectins, e.g. clostridial toxins or Pseudomonas exotoxins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/646Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
FI951276A 1994-03-21 1995-03-17 Parannettuja ominaisuuksia omaavat vasta-ainekonjugaatit FI951276A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP94810173 1994-03-21

Publications (2)

Publication Number Publication Date
FI951276A0 true FI951276A0 (fi) 1995-03-17
FI951276A FI951276A (fi) 1995-09-22

Family

ID=8218230

Family Applications (1)

Application Number Title Priority Date Filing Date
FI951276A FI951276A (fi) 1994-03-21 1995-03-17 Parannettuja ominaisuuksia omaavat vasta-ainekonjugaatit

Country Status (11)

Country Link
JP (1) JPH0820545A (fi)
KR (1) KR950031111A (fi)
AU (1) AU1481795A (fi)
CA (1) CA2144936A1 (fi)
FI (1) FI951276A (fi)
HU (1) HUT71776A (fi)
IL (1) IL113022A (fi)
NO (1) NO951061L (fi)
NZ (1) NZ270734A (fi)
RU (1) RU95104325A (fi)
ZA (1) ZA952269B (fi)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2865737B1 (fr) * 2004-02-03 2006-03-31 Anteis Sa Gel reticule biocompatible

Also Published As

Publication number Publication date
HUT71776A (en) 1996-01-29
IL113022A0 (en) 1995-06-29
KR950031111A (ko) 1995-12-18
FI951276A (fi) 1995-09-22
JPH0820545A (ja) 1996-01-23
ZA952269B (en) 1995-09-21
NO951061L (no) 1995-09-22
NO951061D0 (no) 1995-03-20
IL113022A (en) 2000-02-29
CA2144936A1 (en) 1995-09-22
AU1481795A (en) 1995-09-28
NZ270734A (en) 1997-05-26
RU95104325A (ru) 1996-12-27
HU9500586D0 (en) 1995-04-28

Similar Documents

Publication Publication Date Title
ATE235920T1 (de) Interferon-konjugate
DE69935516D1 (de) Antikörper mit verbesserter produzierbarkeit
NO955167D0 (no) Monoklonalt anti-
ID16966A (id) Sediaan antibodi pekat
DK145493D0 (da) Antistof
DE69435044D1 (de) Rapamycin - Konjugate und Antikörper
DE69938670D1 (de) Streptococcus antigene
DK1421956T3 (da) Polyol-IFN-beta-konjugater
DE69515514D1 (de) Absorbierender artikel mit verbesserten eigenschaften
DE69524185D1 (de) Zwei-walzen-giessverfahren
DK80696A (da) Binding med skraldemekanisme
DE69529288D1 (de) Wasserlösliche polyen-konjugate
NO972868D0 (no) Oligonukleotid-dendrimer konjugater
SE9601050L (sv) Förpackning med avskjutningsanordning
NO974924D0 (no) Modifiserte polypeptider med öket immunogenisitet
DE59507277D1 (de) Falzapparat
ID28905A (id) Antibodi-antibodi dengan afinitas tinggi
FI951276A0 (fi) Parannettuja ominaisuuksia omaavat vasta-ainekonjugaatit
KR950029468U (ko) 때밀이기
SE9002479D0 (sv) Antibody conjugates
DE59504483D1 (de) Positionsmessstrecke
DE69123256D1 (de) Antigen-antikörperkonjugaten
DE59502706D1 (de) Wärmeisolierender körper
FI940841A0 (fi) Lockoeppnare foer konservburk med undertryck
KR950023844U (ko) 쎈추로

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: NOVARTIS AG